explore -WSS

explore

author：entertainment 2025-09-30 17:02:44 - browse：3731

Garry Tan, CEO of Y Combinator Seb Daly/Web Summi

WASHINGTON — In San Francisco, Y Combinator’s firebrand chief executive Garry Tan is one of the startup economy’s most recognizable figures. Well before he became the leader of the coveted startup accelerator that bred global brands like Airbnb, Stripe and OpenAI, Tan was a self-made founder who sold his own company to Twitter.

But here in the nation’s political capital, Tan is far less known. He’s hoping to grow his influence here, offering up his vast network of founders as a source of expertise for regulators struggling to wrap their heads around new technologies like artificial intelligence and how best to rein it in.

“We’re happy to be a phone-a-friend for people who are trying to understand tech,” he told the Economic Club of Washington recently when asked how he’d measure success during Y Combinator’s first-ever policy-focused visit. “‘Little tech’ represents competition, and consumer choice,” he said later at a separate event in a dimly lit Senate room filled with a few dozen Congressional staffers.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alkermes shareholders re
Next article： Where does female orgasm come from? Scientists think they know

WSS

Scientists uncover potential path to treating deadly childhood tumor

Young boy dies in trial for Pfizer Duchenne gene therapy

Covid silver lining: Unprecedented look at human immune system

Overprescribed: High cost isn't America's only drug problem

Statins reduce cardiovascular risk in people living with HIV

Clinic falsely told dozens they had Alzheimer's, suits say

Wikipedia

explore

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

focus

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Scientific mystery highlights the blind spots in genomics databases

Medical leaders decry Supreme Court decision on affirmative action

Harvard scientists, with Google, unveil the most detailed brain map ever

How one medical school became remarkably diverse

Thousands protest mob assault of women who were paraded naked in remote Indian border state

Hepatitis C has a cure — but many Americans still lack access to it

Drug companies' payments and gifts affect physicians' prescribing

Apple is now the first public company to be valued at $3 trillion

Woman found dead after suspected bear encounter near Yellowstone, wildlife officials say

entertainment

How a key Senate committee is planning to regulate PBMs

How to protect coverage of PrEP

Covid silver lining: Unprecedented look at human immune system

New requirements coming in 2024 for Americans traveling to Europe

Medicare Advantage 2025 payments will dip, Biden administration says

Hundreds died while taking an arthritis drug, but nobody alerted patients

entertainment

hotspot

hotspot

focus